Descripción del proyecto
Cooperación internacional para reforzar la preparación ante una pandemia
Las enfermedades infecciosas emergentes (EIE) figuran entre los riesgos más catastróficos para la humanidad. La infraestructura de investigación europea sobre agentes altamente patógenos (ERINHA) y sus socios proponen colaboraciones con infraestructuras de investigación de laboratorios de contención de nivel elevado (HCL, por sus siglas en inglés) de todo el mundo para reforzar las capacidades de preparación y respuesta ante pandemias. El equipo del proyecto INTERCEPTOR, financiado con fondos europeos, pretende mejorar el acceso a los HCL y el capital humano, incluida la formación en gestión de riesgos biológicos, facilitar la puesta en común de recursos críticos y potenciar la armonización y la interoperabilidad. El equipo de INTERCEPTOR se esfuerza por establecer una red mundial sostenible de infraestructuras de investigación de alta contención (HC RI) ampliando el acceso a dichas instalaciones y promoviendo el intercambio de conocimientos, los programas de formación y los intercambios de personal para fortalecer a la próxima generación de investigadores y gestores de instalaciones de HCL.
Objetivo
Emerging infectious diseases (EID) do not respect borders. They rank as global catastrophic risks for humanity, along with climate change and biodiversity loss. The COVID-19 pandemic showed how coordination of global research, through cooperation, and sharing of data and expertise, are crucial for efficient and effective preparedness to EIDs, and vital for a rapid response. Nevertheless, there are still major challenges limiting global cooperation among high containment laboratories (HCLs). HCLs are critical infrastructures for the development of medical countermeasures (e.g. vaccines and therapeutics) against high consequence pathogens. In order to fulfil its role, and given the global threat of EIDs, the European Research Infrastructure on Highly pathogenic Agents (ERINHA), together with its partners, proposes to establish and reinforce interactions with HCL research infrastructures (RI) worldwide, to strengthen pandemic preparedness and response capacities. INTERCEPTOR (INTERnational Cooperation of high containment research infrastructures: from Epidemic Preparedness TO Response), a consortium with key HCLs from Europe and across the world, will focus on access provision to HCLs, enhancement of the human capital of HCL, including in biorisk management, critical resources sharing, harmonisation and interoperability. The proposed actions will help ensure broader access to state-of-the-art HC facilities, while respecting the necessary biosecurity and biosafety constraints, and promote the establishment of a sustainable global network of HC RIs. By expanding access to HC RIs, strengthening the human capital base, promoting sharing of knowledge, skills and experience, and providing opportunities for common training programmes and staff exchanges, INTERCEPTOR will reinforce the next generation of HCL researchers and facility managers, and extend the opportunities for access to HCLs, required to push the boundaries of science and innovation in the field of EIDs.
Ámbito científico
- medical and health scienceshealth sciencespublic healthepidemiologypandemics
- medical and health scienceshealth sciencesinfectious diseasesRNA virusescoronaviruses
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsvaccines
- natural sciencesbiological sciencesecologyecosystems
- natural sciencesearth and related environmental sciencesatmospheric sciencesclimatologyclimatic changes
Palabras clave
Programa(s)
Régimen de financiación
HORIZON-CSA - HORIZON Coordination and Support ActionsCoordinador
1050 Bruxelles / Brussel
Bélgica